Effect of Topiramate in treatment of chronic schizophrenia - Trial IRCT138904014236N1
Access comprehensive clinical trial information for IRCT138904014236N1 through Pure Global AI's free database. This phase not specified trial is sponsored by Mashad university of medical sciences and is currently Completed. The study focuses on Schizophrenia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT138904014236N1
Completed
biological
Trial Details
Iranian Registry Of Clinical Trial • IRCT138904014236N1
Effect of Topiramate in treatment of chronic schizophrenia
Effectiveness of Topiramate augmentation compared with placebo in chronic schizophrenia admitted to Ebnesina and Hejaze Hospitals in Mashad
Study Focus
Sponsor & Location
Mashad university of medical sciences
Iran
Timeline & Enrollment
N/A
Mar 21, 2006
N/A
ICD-10 Classifications
Schizophrenia
Simple schizophrenia
Schizophrenia, unspecified
Other schizophrenia
Paranoid schizophrenia
Data Source
Iranian Registry Of Clinical Trial
IRCT138904014236N1
Non-Device Trial